Clinical Trials Directory

Trials / Completed

CompletedNCT06625736

Anti-obesity Effects of Dandelion (Taraxacum Officinale L.)

Anti-obesity Effects of Dandelion (Taraxacum Officinale L.) in Premenopausal Obese Women: Impacts on Appetite, Energy Intake and Lipid Metabolism

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
October 6 University · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The study investigates the effectiveness of the natural product Dandelion in treating obesity in premenopausal women through a randomized interventional trial, measuring various parameters and biomarkers.

Detailed description

The study aims to explore the anti-obesity effects of dandelion supplementation in premenopausal obese women. The research will measure changes in appetite, energy intake, body weight, composition, lipid profile, and inflammatory markers, providing evidence of dandelion\'s efficacy as an anti-obesity phototherapy. The randomized interventional trial will measure multiple parameters and biomarkers.

Conditions

Interventions

TypeNameDescription
DRUGXenicalThe Xenical group will receive identical capsules 120mg (one capsule) to be taken three times daily with meals, equaling 360mg total daily dose, which aligns with the usage in adult female patients
DIETARY_SUPPLEMENTThe dandelion extractThe dandelion extract group will receive 500 mg capsules of dandelion leaf extract, given 3 times per day before meals.

Timeline

Start date
2024-01-05
Primary completion
2024-09-07
Completion
2024-09-07
First posted
2024-10-03
Last updated
2024-10-03

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06625736. Inclusion in this directory is not an endorsement.